ExceleraRx
Minneapolis, US · Delaware corporation
Find your way into ExceleraRx
Sign up to see every warm intro you have to ExceleraRx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ExceleraRx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SM
Sandra MayasichExecutive
JM
James M. FoxExecutive
GC
George ChresandExecutive
Board
DK
Daniel KusBoard director
RB
Robert BeacherBoard director
NB
Nick BartoBoard director
SP
Scott PetersonBoard director
AZ
Albert ZimmerliBoard director
PN
Pamela NenaberBoard director
Reported raises · per SEC filings
Form D private placements$4.6M disclosed across 2 rounds · 2017–2019
▶$2MraisedNov 2019 · 5 investors · Other Health CareRule 506(b)
▶$2MraisedNov 2019 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- George ChresandExecutive Officer
- Sandra MayasichExecutive Officer
- Daniel KusDirector
- Albert ZimmerliDirector
- Scott PetersonDirector
- Russell FunkDirector
- Robert BeacherDirector
- Troy PolanExecutive Officer, Director
- Craig FrostDirector
- Offering amount
- $6M
- Amount sold
- $2M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.6MraisedJan 2018 · 6 investors · Other Health CareRule 506(b)
▶$2.6MraisedJan 2018 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel KusDirector
- Robert BeacherDirector
- Nick BartoDirector
- Scott PetersonDirector
- Albert ZimmerliDirector
- Sandra MayasichExecutive Officer
- James M. FoxExecutive Officer, Director
- Pamela NenaberDirector
- George ChresandExecutive Officer
- Offering amount
- $5.2M
- Amount sold
- $2.6M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ExceleraRx raised?
- ExceleraRx has disclosed $4.6M raised across 2 rounds.
- Where is ExceleraRx headquartered?
- ExceleraRx is headquartered in Minneapolis, US.